TD Cowen Maintains Buy on Alamar Biosciences, Raises Price Target to $36

Benzinga · 21h ago
TD Cowen analyst Dan Brennan maintains Alamar Biosciences (NASDAQ:ALMR) with a Buy and raises the price target from $34 to $36.